Loading briefing details...
News Brief
By: PointLine Media Research & Editorial Team
Category:Business,Health,Industry,Science & Environment
September 24, 2026
This expansion addresses the critical need for standardized methodologies in the emerging field of plant-based nanomedicine. By streamlining the complex pipeline of vesicle isolation and characterization, Creative Biolabs accelerates the transition from experimental hypothesis to functional validation, significantly lowering barriers for researchers developing next-generation, biocompatible drug delivery systems.
Creative Biolabs has officially expanded its specialized research services to advance the study of plant-derived extracellular vesicles (PDEVs). By leveraging the natural biocompatibility and scalability of these nanovesicles, the company now provides comprehensive support for the isolation, purification, and functional characterization of vesicles sourced from edible plants. These services are specifically engineered to assist researchers in navigating the complexities of biological nanoparticle development and targeted delivery systems.
The company’s enhanced portfolio offers tailored solutions for diverse scientific applications, including strawberry-derived vesicles for skin biology and tissue repair, grapefruit-derived EVs for oral delivery research, and garlic-derived vesicles for studying immune and inflammatory pathways. By providing a standardized, systematic workflow, Creative Biolabs enables investigators to conduct precise analyses of endogenous molecular cargos, such as small RNAs, lipids, and secondary metabolites, within these natural delivery vehicles.
This end-to-end service platform encompasses critical technical milestones, ranging from initial extraction to sophisticated cargo loading—including siRNAs and peptides—and final preclinical evaluation. Through rigorous multi-dimensional characterization techniques like NTA, TEM, and Western blotting, Creative Biolabs empowers the scientific community to explore the potential of plant-based nanocarriers with greater efficiency and reproducibility in both in vitro and in vivo experimental models.